GI
Sangamo Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Isaralgagene civaparvovec (ST-920) | Fabry Disease | Phase 1/2 |
| Giroctocogene fitelparvovec (SB-525) | Hemophilia A | Phase 3 |
| ST-503 | Small Fiber Neuropathy (SFN) | Phase 1/2 |
| ST-506 | Prion Disease | Phase 1/2 |
| TX200 | Renal Transplantation | Phase 1/2 |
| BIVV003 | Sickle Cell Disease | Phase 1/2 |
| Undisclosed ZFP Repressor | Tauopathies | Phase 1/2 |
| Undisclosed Program | Undisclosed Neurology | Preclinical |